• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Life beyond antibodies: quality of life after desensitization in kidney transplantation.

作者信息

Zoehinga Patrice, Jouve Thomas, Chevallier Eloi, Malvezzi Paolo, Rostaing Lionel, Noble Johan

机构信息

Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, University Hospital Grenoble, Grenoble, France.

Univ. Grenoble Alpes, CNRS, Inserm, U 1209 CNRS UMR 5309, Team Epigenetis Immunity, Metabolism, Cell Signaling and Cancer, Institute for Advanced Biosciences, Grenoble, France.

出版信息

Clin Kidney J. 2025 Jan 27;18(3):sfae411. doi: 10.1093/ckj/sfae411. eCollection 2025 Mar.

DOI:10.1093/ckj/sfae411
PMID:40123964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11926592/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a1/11926592/679117b754d4/sfae411fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a1/11926592/679117b754d4/sfae411fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a1/11926592/679117b754d4/sfae411fig1.jpg

相似文献

1
Life beyond antibodies: quality of life after desensitization in kidney transplantation.抗体之外的生活：肾移植脱敏后的生活质量
Clin Kidney J. 2025 Jan 27;18(3):sfae411. doi: 10.1093/ckj/sfae411. eCollection 2025 Mar.
2
Kidney transplantation after desensitization in sensitized patients: a Korean National Audit.致敏患者脱敏后肾移植：韩国国家审计。
Int Urol Nephrol. 2012 Oct;44(5):1549-57. doi: 10.1007/s11255-012-0169-1. Epub 2012 Apr 15.
3
Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients.在接受肾移植的患者中存在供体特异性抗人类白细胞抗原抗体的情况下成功脱敏和肾移植。
Saudi J Kidney Dis Transpl. 2020 Nov-Dec;31(6):1432-1438. doi: 10.4103/1319-2442.308365.
4
Desensitization in Crossmatch-positive Kidney Transplant Candidates.交叉配型阳性的肾移植候选者的脱敏治疗
Transplantation. 2023 Feb 1;107(2):351-360. doi: 10.1097/TP.0000000000004279. Epub 2022 Aug 5.
5
Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.低滴度供者特异性抗体的已故肾供体受者的脱敏方案
Transplant Proc. 2016 Nov;48(9):2880-2883. doi: 10.1016/j.transproceed.2016.07.050.
6
Kidney transplantation across a positive crossmatch: a single-center experience.阳性交叉配型情况下的肾移植：单中心经验
Transplant Proc. 2014 Jul-Aug;46(6):1705-9. doi: 10.1016/j.transproceed.2014.05.012.
7
Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation.活体肾移植脱敏治疗前后可接受的供体特异性抗体水平
Clin Lab. 2020 Jan 1;66(1). doi: 10.7754/Clin.Lab.2019.190706.
8
[Improving access to kidney transplantation for highly sensitized patients: What place for IL-6 pathway blockade in desensitization protocols?].[改善高度致敏患者的肾移植可及性：白细胞介素-6通路阻断在脱敏方案中处于何种地位？]
Nephrol Ther. 2022 Dec;18(7):577-583. doi: 10.1016/j.nephro.2022.07.402. Epub 2022 Oct 31.
9
Desensitization for solid organ and hematopoietic stem cell transplantation.实体器官和造血干细胞移植的脱敏治疗
Immunol Rev. 2014 Mar;258(1):183-207. doi: 10.1111/imr.12150.
10
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.伊沙妥昔单抗单药治疗用于等待肾移植的高致敏患者的脱敏。
J Am Soc Nephrol. 2024 Mar 1;35(3):347-360. doi: 10.1681/ASN.0000000000000287. Epub 2023 Dec 26.

本文引用的文献

1
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates.在高度致敏的肾移植候选受者中，外周记忆B细胞对靶向CD38脱敏治疗的抗HLA血清学反应构成挑战。
Am J Transplant. 2025 Jan;25(1):88-101. doi: 10.1016/j.ajt.2024.08.004. Epub 2024 Aug 10.
2
Advances in desensitization for human leukocyte antigen incompatible kidney transplantation.人类白细胞抗原不相容性肾移植的脱敏治疗进展。
Curr Opin Organ Transplant. 2024 Apr 1;29(2):104-120. doi: 10.1097/MOT.0000000000001131. Epub 2023 Dec 13.
3
Temporal trends in kidney paired donation in the United States: 2006-2021 UNOS/OPTN database analysis.
美国肾对肾捐赠的时间趋势：2006-2021 年 UNOS/OPTN 数据库分析。
Am J Transplant. 2024 Jan;24(1):46-56. doi: 10.1016/j.ajt.2023.09.006. Epub 2023 Sep 20.
4
Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study.免疫吸附法 HLA 脱敏在等待尸体供肾移植患者中的应用：一项介入性、非随机、单队列研究。
Transpl Int. 2023 Aug 23;36:11212. doi: 10.3389/ti.2023.11212. eCollection 2023.
5
Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines.致敏患者肾移植中 Imlifidase 的应用：法国共识指南。
Transpl Int. 2023 Jun 28;36:11244. doi: 10.3389/ti.2023.11244. eCollection 2023.
6
Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients.斯堪的纳维亚移植可接受错配方案-10 年：一种为高致敏患者移植的有效策略。
Am J Transplant. 2022 Dec;22(12):2869-2879. doi: 10.1111/ajt.17182. Epub 2022 Sep 12.
7
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.克拉扎珠单抗在高度致敏患者移植前脱敏中的应用。
Am J Transplant. 2022 Apr;22(4):1133-1144. doi: 10.1111/ajt.16926. Epub 2021 Dec 30.
8
Immortal Time-Bias-Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients.高度致敏患者和HLA脱敏肾移植受者的不朽时间偏差校正生存率
Kidney Int Rep. 2021 Aug 2;6(10):2629-2638. doi: 10.1016/j.ekir.2021.07.024. eCollection 2021 Oct.
9
Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?在肾匹配捐赠和新的肾脏分配系统时代管理高度致敏的肾移植候选者：脱敏治疗是否仍有作用？
Clin Transplant. 2019 Dec;33(12):e13751. doi: 10.1111/ctr.13751. Epub 2019 Nov 26.
10
The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.高致敏受者的全国范围尸肾移植供体情况：KAS 下的移植率、等待名单死亡率和移植后存活率。
Am J Transplant. 2019 Apr;19(4):1129-1138. doi: 10.1111/ajt.15149. Epub 2018 Nov 26.